You just read:

OncoMed Anti-Cancer Stem Cell Antibody OMP-21M18 Demonstrates Potent Activity in Preclinical Studies Against Human Colon Cancer Tumors Regardless of KRAS Mutation Status

News provided by

OncoMed Pharmaceuticals, Inc.

Mar 01, 2011, 04:00 ET